UK Research and Innovation (UKRI), working through its Science and Technology Facilities Council (STFC) and the National Quantum Computing Centre (NQCC), named four startups in the DeepTech Catalyst Quantum (DTC Quantum) programme on 14 April 2026 at the Harwell campus: Curenetics (quantum and AI for cancer-vaccine targets), Coherence Engine (quantum control-system software), AmorphiQ (quantum and AI for materials degradation), and Qascade (light-based ultra-fast data movement). Each receives £50,000 to £100,000 in R&D funding plus 50 hours of business support and investor introductions. 1
DTC Quantum is the operating Arm of the DeepTech Catalyst, founded in 2011 and now hosted at NQCC. The wider Catalyst has backed more than 230 startups, collectively raising over £300m in private follow-on and supporting roughly 1,100 jobs, with a claimed 95% company survival rate and a £25 return for every £1 of public money deployed. Quantum joined the programme as a dedicated vertical when the UK committed £2bn to quantum commercialisation via ProQure ; DTC Quantum is the demand-side complement to ProQure's supply-side infrastructure.
The four selections map to the four layers of a working quantum stack: algorithms and applications (Curenetics, AmorphiQ), control software (Coherence Engine), and photonic interconnect (Qascade). That the UK can field one startup in each layer is the point; quantum commercialisation breaks if any rung is missing. None of the four has the capital to build at scale on £50k-£100k alone. The DTC money is a signal-and-support package designed to make them raisable, not a runway.
NQCC and STFC will be judged on the eighteen-month follow-on rate. If three of the four close private rounds above £2m by late 2027, ProQure has its commercial pipeline. If only one does, the vehicle gap between DTC tickets and ProQure's commercialisation infrastructure becomes the next policy fight. The ratio will matter more than the cohort itself.
